GlassScriptPhysician profile
Patrick J Losito
NPI 1730294851
$1,438.03
in general payments reported to CMS, 2019-2025
7 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $256 · 2022: $117 · 2023: $286 · 2024: $497 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $938.45 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $251.10 | 2021-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve, Konect Resilia |
| Medical Device Business Services, INC. | $72.28 | 2024 | Vistaseal |
| Terumo Cardiovascular Systems Corporation | $71.79 | 2023-2025 | Terumo Advanced Perfusion System 1, Capiox Fx Advance Hollow Fiber Oxygenator W Integrated Af W Hardshell Res., Cdi Blood Parameter Monitoring System 550 |
| Getinge USA Sales, LLC | $52.15 | 2021-2022 | |
| Medtronic, INC. | $31.44 | 2022-2023 | Corevalve Evolut R |
| Boston Scientific Corporation | $20.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Losito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.